The slip
PARKINSON RECEIPTno. 13199
28 Oct 2026, 16:37 UTCdopamine neurons, braak
predictionSYNPO in dopamine neurons tracks Braak Lewy-body stage
registered94d8c1b5c6f9a8f1
discovery-0.36 p=0.347 n=9
replication-0.08 p=0.838 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.36, p 0.347)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe9c4f2042231e5a98ab7c248…
follows 8d865374a53e…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13199: SYNPO in dopamine neurons, braak
- power
- full sample -0.23 (p 0.360, n 18), 95% CI -0.63 to +0.27. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.24 (p 0.328, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.38 (p 0.116, n 18). could be the mix.
- skeptic
- leave-one-out range -0.38 to -0.14, sign flips 0; without severely affected donors -0.23 (p 0.360, n 18). fragile.
- cell type
- strongest in astrocytes: -0.65 (p 0.0037, n 18) vs -0.23 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SYNPO in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SYNPO · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.65 p 0.021 (needs p < 1.7e-4)